Table 1 Demographics of patients who were discharged by their lead clinician from further follow up, and their outcomes of treatment, divided into those who were discharged due to visual acuity worse than treatment criteria, and those who had stable inactive disease, not requiring further treatment.

From: Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration

 

Discharged from follow up

Total number of patients

116

Mean Age (years), range

87.15, 62–103

Gender:

Male, number/total, %

45/116, 38.2%

Female, number/total, %

71/116, 61.2%

 

Stopped because below treatment criteria

Stable inactive disease

LogMAR visual acuity at initiation of treatment, mean

0.96

0.61

LogMAR visual acuity at last recorded appointment, mean

1.68

0.49

Number/total whose visual acuity deteriorated over the treatment period, percentage

37/45, 83%

13/71, 18%

Months in treatment, mean

32.58

32.22

Number of anti-VEGF injections, mean

7.02

6.42

Back to article page